查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866938

体外循环系统市场按产品类型、组件、技术、应用和最终用户划分－2025年至2032年全球预测

Extracorporeal Circulation System Market by Product Type, Component, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，体外循环系统市场规模将达到 27.8 亿美元，复合年增长率为 8.36%。

关键市场统计数据
基准年 2024 14.6亿美元
预计年份：2025年 15.8亿美元
预测年份 2032 27.8亿美元
复合年增长率 (%) 8.36%

一个不断演进的临床和技术要求框架，它定义了体外循环系统，并影响采购和实施决策。

现代体外循环系统领域在心臟外科手术和高阶呼吸支援的交叉领域发挥核心作用，这得益于技术的不断进步和临床通讯协定的不断发展。近年来，随着医院和专科医疗中心在复杂心臟心血管手术和严重呼吸衰竭治疗方面的能力提升，心肺体外迴圈机和体外膜氧合（ECMO）平台都受到了越来越多的关注。本文概述了这个生态系统，重点介绍了临床驱动因素、组件层面的创新以及影响采购和实施决策的政策背景。

临床医生越来越需要整合安全功能、易于启动和简化工作流程的系统，以缩短手术时间并提高患者吞吐量。同时，製造商正在追求模组化架构，以实现更小的尺寸、更高的生物相容性和针对多种适应症的快速配置。支付方和医疗系统要求提供可证明的临床价值，因此，基于结果的证据和能够减少加护病房住院时间的流程的重要性日益凸显。因此，相关人员应将体外循环视为一个包含设备、耗材、培训和售后支援的临床服务包，而不仅仅是硬体。

展望未来，决策者必须认真考虑临床疗效、营运效率和生命週期成本，以及监管要求和供应链韧性，以使投资与组织优先事项保持一致，提高患者安全，并在医疗保健机构中维持先进的急性护理服务。

找出正在迅速改变体外循环系统开发和应用的技术进步、不断发展的临床实践以及监管压力。

体外循环领域正经历着一场变革性的转变，其驱动力包括泵浦技术、氧合器设计和系统整合方面的创新，以及临床实践模式的改变和监管机构对安全性和实际应用性能的日益重视。离心泵和磁浮泵因其溶血率低、流量控制更佳而日益普及，而氧合器的进步则主要集中在气体交换效率和血栓形成倾向的降低。这些技术进步催生了新的系统结构，这些架构强调整合解决方案、可携式平台和一次性组件策略，从而降低了交叉感染的风险。

随着体外膜氧合（ECMO）适应症范围的扩大，临床通讯协定也不断调整。 ECMO在重症呼吸衰竭和移植过渡治疗中的应用，使得对可在加护病房和手术全期手术期快速部署的灵活的静脉-动脉（VA）和静脉-静脉（VV）配置的需求日益增长。同时，医院也更加重视缩短泵浦运转运作和加快病患恢復，这使得设备的符合人体工学的设计、快速设定和直觉的监测介面变得尤为重要。

监管机构日益重视上市后监测、临床资料提交以及关键零件的可追溯性。这种监管力度的加强促使製造商加强对品质系统和临床证据产生的投入。此外，供应链中断也提升了供应链韧性的策略重要性，促使製造商实现製造地多元化并加强与供应商的关係。这些因素共同推动着整个产业朝着更安全、更具适应性且更符合现代医疗路径的方向发展。

了解近期关税发展和贸易政策变化如何影响您所在行业的采购调整、成本再平衡和策略性製造应对措施。

2025年美国关税调整、贸易政策审查和进口限制的累积效应，正为体外循环生态系中的製造商、经销商和终端用户带来巨大的复杂性。进口医疗组件和成品医疗设备的关税变化可能会改变到岸成本，促使企业重新评估筹资策略，并加速产能转移和近岸外包。因此，拥有全球供应链的企业必须调整其跨国采购惯例，以适应新的关税环境。

实际上，提高进口关税可能会促使企业增加组装的国产化率，从而带动对本地製造业的资本投资或与美国本土契约製造的合作。虽然这些措施能够提高供应可靠性并降低物流中断的风险，但寻找替代供应商并确保设备和零件符合监管要求需要时间和资金。医院和专科诊所可能会在短期内遇到采购方面的摩擦，因为经销商需要调整价格和库存策略，但从中长期来看，供应商透明度的提高和前置作业时间的缩短将使它们受益。

政策主导的成本压力将进一步激励医疗设备製造商加快设计变革，旨在减少材料用量、提高模组化程度并实现在地化生产。总体而言，各组织应预见一段过渡期，其特点是成本重新平衡、供应商整合以及旨在增强长期韧性并适应新贸易环境的策略投资。

对产品、组件、技术、应用和最终用户进行细分，以确定差异化的临床需求和产业战略路径。

了解细分市场的细微差别对于解读体外循环解决方案的产品开发路径和临床应用至关重要。根据产品类型，体外循环解决方案可分为心肺体外迴圈系统和体外膜氧合（ECMO）平台。心肺体外迴圈方案提供整合式和独立式两种形式，而ECMO则应用于心臟和呼吸系统：静脉-动脉和静脉-静脉途径。每类产品在工程设计、消毒和临床培训方面都有不同的要求，这些要求会影响医疗机构的采用模式。

组件层面的细分有助于明确技术供应链与临床绩效之间的权衡。热交换器分为板式和管式两种，其热效率和预充能力各不相同。氧合器分为中空纤维式和膜式两种，气体交换特性也各有差异。泵的类型包括离心泵、磁浮和滚压泵，这些类型在剪切应力和维护要求方面存在差异。管路材质的选择范围很广，从PVC到硅胶，每种材质的生物相容性和操作特性都不同。这些组件的选择会影响设备的寿命、处置策略以及临床医生的偏好。

技术细分进一步凸显了离心泵、磁浮和滚压泵在血液相容性、体积和整合复杂性方面各自独特的优势，从而指导研发投资方向。应用细分区分了心臟外科手术适应症（例如冠状动脉绕道手术手术、瓣膜置换术和血管外科手术）和呼吸支持应用情境（例如急性呼吸窘迫症候群、移植过渡治疗和 COVID 相关 ECMO 部署）。最后，终端使用者细分区分了进行心臟日间手术的门诊手术中心、由综合心臟中心和专科心臟中心组成的医院，以及儿科中心和研究机构等专科诊所。这些相互交织的细分维度共同构成了一个多维整体情况，指导产品定位、服​​务设计和市场推广策略。

绘製美洲、欧洲、中东和非洲以及亚太地区在监管、临床和采购模式方面的差异图，以帮助制定区域商业化策略。

区域趋势对体外循环领域的监管方式、采购行为和临床实务模式有显着影响。在美洲，集中化的报销机制和对循证实践的高度重视，促使製造商投资于临床试验和上市后监测，而医疗服务提供者则优先选择那些能够展现明显运营优势并改善患者预后的器械。该地区也倾向于与当地分销商建立策略合作伙伴关係，以保持对先进急诊中心的快速回应能力。

欧洲、中东和非洲地区的法规环境差异显着，这要求製造商配备灵活的监管和市场进入小组，以应对各种不同的核准流程和报销制度。临床试验中心的选择通常需要在成本控制和采用先进技术之间取得平衡，从而推动了对可根据设施能力量身定制的模组化解决方案的需求。全部区域供应链的分散性促使製造商与区域物流专家和本地服务供应商建立合作关係，以确保耗材和维护的连续性。

在亚太地区，专科医院的快速扩张以及对三级心臟和呼吸系统医疗项目投资的不断增长，推动了对整合系统和组件供应的需求。现代化的监管和日益精细化的临床专业化促进了先进泵浦和氧合器技术的应用，而多个国家的本土化生产则有助于降低价格。因此，相关人员应采取区域专业化策略，使产品组合、培训计画和服务模式与当地的临床工作流程和采购惯例相契合。

透过系统整合、组件创新、临床证据产生和供应链策略定位来评估竞争差异化优势

体外循环系统市场的竞争格局是由成熟的设备产品组合和专业工程公司快速创新相结合而成，这种格局使得合作、收购和共同开发契约成为普遍现象。老牌製造商利用其品牌知名度和全球服务网络，持续为医院和专科心臟中心提供产品；而新兴参与企业则透过在泵浦技术、氧合器膜和一次性耗材设计方面进行重点改进，降低手术复杂性，从而挑战现有企业的地位。

策略差异化日益聚焦于系统整合、临床医生培训服务以及能够提供即时性能数据并支援预防性维护的数位监测能力。投资于包含硬体、一次性耗材、软体分析和教育项目的端到端解决方案的公司更有可能与医疗系统建立长期合作关係。同时，能够提供小批量客製化和快速原型製作服务的零件供应商，对于寻求加速产品改进的原始设备製造商 (OEM) 而言，也是极具吸引力的合作伙伴。

供应链管理也是竞争的关键。拥有多元化製造地并与关键原材料供应商保持深厚合作关係的公司，在应对供应中断和关税影响方面更具优势。监管方面的专业知识和强大的临床证据基础能够进一步提升竞争优势，因为支付方和医疗服务提供方的采购团队越来越重视那些能够在产品生命週期内展现卓越绩效和提供支持的供应商。

製造商和医疗保健系统提高体外循环系统采用率、增强供应链韧性和加强临床证据的实用策略

体外循环领域的领导企业应采取一系列切实可行的措施，充分利用技术发展势头，同时降低营运和政策风险。应优先投资于血液相容性材料、低预充量设计以及可快速重新配置以支援静脉-动脉和静脉循环的模组化架构。这将使製造商能够减轻临床医生的负担，并满足从心臟手术到呼吸支持等广泛的临床应用需求。

同时，企业应制定区域性生产和包装策略，以降低关税风险并缩短前置作业时间。与关键地区的委託製造建立牢固的合作关係或加强国内组装能力，可以降低供应方面的脆弱性。这些措施，结合稳健的库存计画和关键零件的多元化供应来源，可以进一步保障业务营运免受中断的影响。

透过有针对性的註册研究和以降低溶血、提高氧合效率和减少器械相关併发症等结果为重点的实用临床研究，加强临床证据的产生。投资临床医生培训计画和基于模拟的课程，以加速安全应用并提升系统在市场上的受欢迎程度。最后，积极与监管机构和支付方沟通，协调产品标籤、报销代码和上市后监测的预期。这将有助于产品进入市场并支持长期的商业性永续性。

我们描述了一种多来源研究途径，该方法结合了临床医生访谈、技术整合和数据三角测量，以提供有关医疗设备和临床实践动态的检验见解。

本执行摘要的调查方法融合了初步定性研究和全面的二次分析，以确保研究结果的可靠性和可重复性。一级资讯来源包括：心臟科和加护治疗临床医生、医院和专科诊所的采购主管以及医疗设备製造商的高级工程领导。这些初步研究主要关注临床工作流程、器械性能特征、采购限制以及技术发展的预期趋势。

二次研究涵盖了监管申报文件、同行评审的临床文献、医疗设备技术规范和政策文件，以检验技术声明并分析区域监管差异。研究采用数据三角测量技术来调和不同观点，并识别不同临床环境和地区之间的一致模式。此外，分析还纳入了组件层面的技术比较，以揭示泵浦类型、氧合器结构和材料选择的权衡取舍。

为确保研究质量，关键发现由独立的临床顾问进行交叉检验，并经过反覆审查以完善解读。儘管存在一些限制因素，例如临床实践的快速发展和各地采购政策的潜在差异，但调查方法调查方法优先考虑透明度和可追溯性，有助于相关人员做出更有信心的决策。

我们概述了临床需求、组件创新和政策驱动因素的融合，以确定决定体外循环解决方案可扩展采用的因素。

总之，体外循环领域正迈入一个以系统整合、组件层级改进以及对实证医学和供应稳定性日益增长的需求为特征的阶段。临床上对可靠的静脉-动脉和静脉-静脉配置的需求，以及对能够最大限度减少血液损伤并简化工作流程的泵和氧合器的偏好，持续影响着产品开发计划。同时，政策变化和区域采购趋势正迫使製造商和供应商重新评估其采购、生产和商业化策略。

将产品设计与临床医生需求相结合、投资于可验证的临床结果并建立灵活的供应链网络的相关人员，将获得竞争优势，同时提升患者安全并增强医疗机构应对复杂心臟和呼吸系统病例的能力。技术创新、法规遵循和营运可行性之间的相互作用，将决定哪些解决方案能够有效地推广到各种医疗机构，从门诊心臟日间手术中心到三级医疗中心和儿科专科计画。

总体而言，对模组化、证据生成和区域合作的战略重点将使体外循环能力得以永续应用，从而满足当代临床和组织的需求。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧驱动的预测分析整合到体外循环管理中，以改善患者预后
  • 开发生物相容性涂层技术，以最大限度地减少体外循环过程中血栓的形成
  • 携带式体外膜氧合（ECMO）系统在院外严重患者照护的应用日益广泛
  • 在心臟手术中采用封闭回路型自动灌注控制，以优化血流并减少併发症
  • 监管机构推动体外循环装置标准化安全通讯协定和即时监测
  • 医疗设备製造商与学术研究人员合作，提高氧合器薄膜的耐久性和效率
  • 一种专门用于经皮介入心臟病学的微创体外循环支持系统的出现

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 体外循环系统市场（依产品类型划分）

  • 心肺体外迴圈系统
    • 整合系统
    • 独立系统
  • 体外膜氧合器
    • 静脉-动脉体外膜氧合（ECMO）
    • 静脉-静脉体外膜氧合（VV-ECMO）

第九章 体外循环系统市场（依组件划分）

  • 热交换器
    • 板式热交换器
    • 管式热交换器
  • 氧合设备
    • 中空纤维氧合器
    • 膜式氧合器
  • 泵浦
    • 离心式帮浦
    • 磁浮泵浦
    • 滚筒帮浦
  • 管子
    • 聚氯乙烯管
    • 硅胶管

第十章 体外循环系统市场（依技术划分）

  • 离心式帮浦
  • 磁浮泵浦
  • 滚筒帮浦

第十一章 体外循环系统市场（依应用领域划分）

  • 心臟手术
    • 冠状动脉绕道手术手术
    • 阀门置换术
    • 血管外科
  • 呼吸辅助
    • 急性呼吸窘迫症候群
    • 移植桥樑
    • ECMO用于COVID-19患者

第十二章 体外循环系统市场（依最终用户划分）

  • 门诊手术中心
    • 心臟日间手术
  • 医院
    • 综合医院
    • 专业心臟中心
  • 专科诊所
    • 儿科中心
    • 研究所

第十三章 体外循环系统市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 体外循环系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国体外循环系统市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Terumo Corporation
    • Getinge AB
    • LivaNova PLC
    • Fresenius Medical Care AG & Co. KGaA
    • Baxter International Inc.
    • Edwards Lifesciences Corporation
    • Nipro Corporation
    • B. Braun Melsungen AG
    • Nikkiso Co., Ltd.
Product Code: MRR-CD5A9334D17A

The Extracorporeal Circulation System Market is projected to grow by USD 2.78 billion at a CAGR of 8.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.46 billion
Estimated Year [2025] USD 1.58 billion
Forecast Year [2032] USD 2.78 billion
CAGR (%) 8.36%

Framing the evolving clinical and technological imperatives that define extracorporeal circulation systems and influence procurement and adoption decisions

The contemporary field of extracorporeal circulation systems occupies a central role at the intersection of cardiac surgery and advanced respiratory support, powered by continuous technological refinement and evolving clinical protocols. Recent years have seen intensified focus on both cardiopulmonary bypass equipment and extracorporeal membrane oxygenation platforms as hospitals and specialty centers expand capabilities to manage complex cardiac operations and severe respiratory failure. This introductory overview frames the ecosystem by emphasizing clinical drivers, component-level innovation, and the policy context that shapes procurement and adoption decisions.

Clinicians increasingly demand systems that integrate safety features, ease of priming, and streamlined workflow to reduce operative time and improve patient throughput. Simultaneously, manufacturers pursue miniaturization, improved biocompatibility, and modular architectures that permit rapid configuration for diverse indications. Payers and health systems are pressing for demonstrable clinical value, which elevates the importance of outcomes-based evidence and procedures that shorten intensive care utilization. Therefore, stakeholders should view extracorporeal circulation not simply as hardware, but as a clinical service bundle comprising devices, disposables, training, and post-market support.

Moving forward, decision-makers must weigh clinical effectiveness, operational efficiency, and lifecycle cost while navigating regulatory expectations and supply chain resiliency. In doing so, they can align investments with institutional priorities to enhance patient safety and sustain high-acuity services across care settings.

Identifying the technological advances, clinical practice evolution, and regulatory pressures that are rapidly reshaping extracorporeal circulation system development and adoption

The landscape surrounding extracorporeal circulation is undergoing transformative shifts driven by innovation in pump technologies, oxygenator design, and systems integration, alongside changing clinical practice patterns and regulatory emphasis on safety and real-world performance. Centrifugal and magnetic levitation pumps have gained traction due to reduced hemolysis and improved flow control, while oxygenator advancements focus on gas exchange efficiency and thromboresistance. These engineering improvements enable newer system architectures that favor integrated solutions, portable platforms, and disposable component strategies that lower cross-contamination risk.

Clinical protocols are adapting as extracorporeal membrane oxygenation expands beyond traditional indications. Use in severe respiratory failure and as a bridge to transplant has created demand for flexible venoarterial and venovenous configurations that can be rapidly deployed in intensive care and perioperative environments. In parallel, hospitals emphasize shorter pump run times and faster recovery, which elevates the importance of device ergonomics, rapid setup, and intuitive monitoring interfaces.

Regulatory bodies increasingly require post-market surveillance, clinical data submission, and traceability for critical components. This regulatory tightening encourages manufacturers to invest in quality systems and clinical evidence generation. Additionally, supply chain resilience has ascended as a strategic priority following disruptions, prompting diversification of manufacturing footprints and stronger supplier relationships. Taken together, these forces are pushing the sector toward systems that are safer, more adaptable, and better aligned with contemporary care pathways.

Understanding how recent tariff developments and trade policy shifts contribute to sourcing realignment, cost rebalancing, and strategic manufacturing responses in the sector

The cumulative effect of tariff adjustments, trade policy revisions, and import restrictions implemented in the United States during 2025 introduces a material layer of complexity for manufacturers, distributors, and end users in the extracorporeal circulation ecosystem. Tariff changes on imported medical components and finished devices can alter landed costs, prompt re-evaluation of sourcing strategies, and accelerate relocation or nearshoring of production capabilities. Organizations with global supply chains must therefore reconcile cross-border procurement practices with the new duty environment.

In practice, increased import duties incentivize higher domestic content in assemblies, which can lead to capital investment in local manufacturing or partnerships with U.S.-based contract manufacturers. While such efforts can improve supply reliability and reduce exposure to logistic disruptions, they also require time and capital to qualify alternate suppliers and to ensure regulatory compliance for devices and components. Hospitals and specialty clinics might experience short-term procurement friction as distributors adjust pricing and inventory policies, but they may also benefit from improved vendor transparency and shorter lead times over the medium term.

Policy-driven cost pressures further motivate device makers to accelerate design changes that lower material intensity, enhance modularity, and enable regionalized production. In sum, organizations should anticipate a transition period marked by cost rebalancing, supplier consolidation, and strategic investments aimed at long-term resilience and alignment with the revised trade landscape.

Dissecting product, component, technology, application, and end-user segmentation to reveal differentiated clinical needs and industrial strategic pathways

A nuanced understanding of segmentation is essential to interpret product development pathways and clinical alignment across extracorporeal circulation offerings. Based on product type, the landscape encompasses cardiopulmonary bypass systems and extracorporeal membrane oxygenation platforms; cardiopulmonary bypass solutions present as integrated systems as well as standalone systems, while extracorporeal membrane oxygenation is deployed in venoarterial and venovenous modalities tailored to cardiac and respiratory indications respectively. Each product class imposes distinct engineering, sterilization, and clinical training requirements, which in turn influence adoption patterns across institutions.

Component-level segmentation clarifies technology supply chains and clinical performance trade-offs. Heat exchangers are available as plate and tubular designs with different thermal efficiencies and priming volumes; oxygenators are realized through hollow fiber and membrane constructions that vary in gas exchange properties; pumps include centrifugal, magnetic levitation, and roller formats that drive differences in shear stress and maintenance needs; tubing options span PVC and silicone, each with discrete biocompatibility and handling characteristics. These component choices shape device lifetime, disposables strategies, and clinician preferences.

Technology segmentation further highlights that centrifugal, magnetic levitation, and roller pump approaches each present unique benefits vis-a-vis hemocompatibility, footprint, and integration complexity, thereby guiding R&D investment. Application segmentation distinguishes cardiac surgery indications such as coronary artery bypass grafting, valve replacement, and vascular surgery from respiratory support use cases including acute respiratory distress syndrome, bridge to transplant, and COVID-related ECMO deployment. Finally, end-user segmentation differentiates ambulatory surgery centers with cardiac day surgery workflows, hospitals comprising general and specialized cardiac centers, and specialty clinics such as pediatric centers and research institutes. Together, these intersecting segmentation vectors create a multi-dimensional picture that informs product positioning, service design, and go-to-market strategies.

Mapping divergent regulatory, clinical, and procurement patterns across the Americas, Europe Middle East and Africa, and Asia Pacific to inform regional commercialization strategies

Regional dynamics exert a powerful influence on regulatory approach, procurement behavior, and clinical practice patterns across the extracorporeal circulation domain. In the Americas, centralized reimbursement frameworks and a strong emphasis on evidence-based adoption encourage manufacturers to invest in clinical trials and post-market studies while healthcare providers prioritize devices that demonstrate clear operational and patient outcome benefits. This region also favors strategic partnerships with local distributors to maintain rapid response capabilities for high-acuity centers.

In Europe, Middle East & Africa, regulatory environments vary considerably, prompting manufacturers to maintain flexible regulatory and market access teams that can navigate divergent approval pathways and reimbursement regimes. Clinical preferences often reflect a balance between cost containment and the adoption of advanced technology, which spurs modular solutions that can be tailored by facility capability. Supply chain fragmentation across the region incentivizes partnerships with regional logistics specialists and local service providers to ensure continuity of consumables and maintenance.

Across Asia-Pacific, rapid capacity expansion of specialty hospitals and increasing investment in tertiary cardiac and respiratory programs are driving demand for both integrated systems and component supplies. Regulatory modernization and rising clinical expertise support adoption of advanced pump and oxygenator technologies, while domestic manufacturing in several countries contributes to competitive pricing dynamics. Stakeholders should therefore adopt region-specific strategies that align product configurations, training programs, and service models with local clinical workflows and procurement practices.

Evaluating competitive differentiation driven by systems integration, component innovation, clinical evidence generation, and supply chain strategic positioning

Competitive dynamics within extracorporeal circulation systems combine legacy device portfolios with rapid innovation from specialized engineering firms, creating a landscape in which partnerships, acquisitions, and co-development agreements are common. Established manufacturers continue to leverage brand recognition and global service networks to supply hospitals and specialized cardiac centers, while emerging entrants challenge incumbents through focused improvements in pump technology, oxygenator membranes, and disposable consumable design that reduce procedural complexity.

Strategic differentiation increasingly centers on systems integration, clinician training services, and digital monitoring capabilities that provide real-time performance data and enable preventive maintenance. Companies that invest in end-to-end solutions-comprising hardware, disposables, software-enabled analytics, and education programs-tend to secure longer-term relationships with health systems. At the same time, component suppliers that offer low-volume customization and rapid prototyping are attractive partners for original equipment manufacturers seeking to accelerate product enhancements.

Supply chain control is another axis of competition; firms that maintain diversified manufacturing footprints and deep supplier relationships for critical materials are better positioned to manage disruptions and tariff impacts. Regulatory expertise and a robust clinical evidence base further amplify competitive advantage, as payers and provider procurement teams increasingly favor suppliers who can demonstrate outcomes and support across the product lifecycle.

Actionable strategies for manufacturers and health systems to accelerate adoption, build supply resilience, and strengthen clinical evidence supporting extracorporeal systems

Leaders in the extracorporeal circulation space should adopt a set of pragmatic actions to capitalize on technological momentum while mitigating operational and policy risks. Prioritize investments in hemocompatible materials, low-prime-volume designs, and modular architectures that enable rapid reconfiguration for venoarterial or venovenous support. By doing so, manufacturers can reduce clinician burden and broaden the addressable clinical use cases across cardiac surgery and respiratory support.

Concurrently, develop regional manufacturing and packaging strategies to mitigate tariff exposure and improve lead times. Establishing validated partnerships with contract manufacturers in key geographies or enhancing domestic assembly capabilities will reduce supply fragility. Complementing these moves with robust inventory planning and multi-sourcing for critical components will further insulate operations from disruption.

Strengthen clinical evidence generation through targeted registries and pragmatic clinical studies focused on outcomes such as hemolysis rates, oxygenation efficiency, and device-related complication reduction. Invest in clinician training programs and simulation-based curricula to accelerate safe adoption and to build preference for your systems. Finally, engage proactively with regulators and payers to align product labeling, reimbursement coding, and post-market surveillance expectations, which will smooth market access and support longer-term commercial sustainability.

Explaining the multi-source research approach that combines clinician interviews, technical synthesis, and data triangulation to deliver validated insights into device and clinical practice dynamics

The research methodology underpinning this executive summary integrates a blend of primary qualitative inquiry and comprehensive secondary source synthesis to ensure robust, reproducible insights. Primary inputs included structured interviews with practicing cardiac and critical care clinicians, procurement executives from hospitals and specialty clinics, and senior engineering leaders within device firms. These conversations focused on clinical workflows, device performance attributes, procurement constraints, and anticipated technology trajectories.

Secondary research encompassed regulatory filings, peer-reviewed clinical literature, device technical specifications, and policy documents to validate technical claims and to contextualize regional regulatory differences. Data triangulation techniques were applied to reconcile divergent viewpoints and to identify consistent patterns across clinical settings and geographies. The analysis also incorporated component-level technical comparison to illuminate trade-offs between pump types, oxygenator constructions, and material choices.

Quality assurance included cross-validation of key findings with independent clinical advisors and iterative review cycles to refine interpretations. Limitations pertain to rapidly evolving clinical practice and potential variability in local procurement policies; nonetheless, the methodological approach prioritizes transparency and traceability to support confident decision-making by stakeholders.

Summarizing the convergence of clinical demand, component innovation, and policy drivers that will determine the scalable adoption of extracorporeal circulation solutions

In conclusion, the extracorporeal circulation domain is transitioning to a phase characterized by integrated systems, component-level refinement, and heightened expectations for evidence and supply resilience. Clinical demand for reliable venoarterial and venovenous configurations, coupled with preferences for pumps and oxygenators that minimize blood trauma and streamline workflows, continues to shape product roadmaps. At the same time, policy changes and regional procurement dynamics compel manufacturers and providers to reassess sourcing, manufacturing, and commercialization strategies.

Stakeholders who align product design with clinician needs, invest in demonstrable clinical outcomes, and build flexible supply networks will secure competitive advantage while enhancing patient safety and institutional readiness for complex cardiac and respiratory cases. The interplay between technological innovation, regulatory diligence, and operational execution will determine which solutions scale effectively across diverse care settings, from ambulatory cardiac day surgery facilities to tertiary referral centers and specialized pediatric programs.

Overall, a strategic focus on modularity, evidence generation, and regional alignment will enable durable adoption of extracorporeal circulation capabilities that meet contemporary clinical and organizational imperatives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven predictive analytics in extracorporeal circulation management to enhance patient outcomes
  • 5.2. Development of biocompatible coating technologies to minimize thrombus formation during extracorporeal procedures
  • 5.3. Rising adoption of portable extracorporeal membrane oxygenation systems for out-of-hospital critical care support
  • 5.4. Shift towards closed-loop automated perfusion control in cardiac surgery to optimize blood flow and reduce complications
  • 5.5. Regulatory impetus for standardized safety protocols and real-time monitoring in extracorporeal circulation devices
  • 5.6. Collaboration between medical device manufacturers and academic researchers to improve oxygenator membrane durability and efficiency
  • 5.7. Emergence of minimally invasive extracorporeal circulatory support systems tailored for percutaneous cardiovascular interventions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal Circulation System Market, by Product Type

  • 8.1. Cardiopulmonary Bypass System
    • 8.1.1. Integrated Systems
    • 8.1.2. Standalone Systems
  • 8.2. Extracorporeal Membrane Oxygenation
    • 8.2.1. Venoarterial Ecmo
    • 8.2.2. Venovenous Ecmo

9. Extracorporeal Circulation System Market, by Component

  • 9.1. Heat Exchanger
    • 9.1.1. Plate Heat Exchanger
    • 9.1.2. Tubular Heat Exchanger
  • 9.2. Oxygenator
    • 9.2.1. Hollow Fiber Oxygenator
    • 9.2.2. Membrane Oxygenator
  • 9.3. Pump
    • 9.3.1. Centrifugal Pump
    • 9.3.2. Magnetic Levitation Pump
    • 9.3.3. Roller Pump
  • 9.4. Tubing
    • 9.4.1. Pvc Tubing
    • 9.4.2. Silicone Tubing

10. Extracorporeal Circulation System Market, by Technology

  • 10.1. Centrifugal Pump
  • 10.2. Magnetic Levitation Pump
  • 10.3. Roller Pump

11. Extracorporeal Circulation System Market, by Application

  • 11.1. Cardiac Surgery
    • 11.1.1. Coronary Artery Bypass Grafting
    • 11.1.2. Valve Replacement
    • 11.1.3. Vascular Surgery
  • 11.2. Respiratory Support
    • 11.2.1. Acute Respiratory Distress Syndrome
    • 11.2.2. Bridge To Transplant
    • 11.2.3. Covid Ecmo

12. Extracorporeal Circulation System Market, by End User

  • 12.1. Ambulatory Surgery Centers
    • 12.1.1. Cardiac Day Surgery
  • 12.2. Hospitals
    • 12.2.1. General Hospitals
    • 12.2.2. Specialized Cardiac Centers
  • 12.3. Specialty Clinics
    • 12.3.1. Pediatric Centers
    • 12.3.2. Research Institutes

13. Extracorporeal Circulation System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal Circulation System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal Circulation System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtronic plc
    • 16.3.2. Terumo Corporation
    • 16.3.3. Getinge AB
    • 16.3.4. LivaNova PLC
    • 16.3.5. Fresenius Medical Care AG & Co. KGaA
    • 16.3.6. Baxter International Inc.
    • 16.3.7. Edwards Lifesciences Corporation
    • 16.3.8. Nipro Corporation
    • 16.3.9. B. Braun Melsungen AG
    • 16.3.10. Nikkiso Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. EXTRACORPOREAL CIRCULATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. EXTRACORPOREAL CIRCULATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL CIRCULATION SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MI